Becton, Dickinson and Company Common Stock · Transaction May 21, 2026 · Filed Jun 18, 2026 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · BDX
-1.04% · -$2.01 · Vol Not reported
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Becton Dickinson and Co
Health Care
$191.75
Follow $BDX
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $BDX by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredFri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET · BDX
MethodologyBDX
Becton Dickinson and Co
Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
Highest qualified
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
76/ 100
Veridion Score
Highest qualified · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
AI Analysis
SovereignWhy is BDX moving today?
Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Becton Dickinson and Co
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
1963
Employees
72K
Country
US
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$194.42
Day high
$195.99
Day low
$190.21
Previous close
$193.76
52W high
$195.99
-2.16% from high
52W low
$138.67
93% of range
Market cap
$52.2B
P/E
55.45×
EPS
$3.31
Beta
-0.01
Shares out
272.4M
Avg volume
1.8M
VWAP
$193.76
Last session
Price history computed in-house
1W
+4.35%
1M
+5.97%
3M
+24.13%
1Y
+28.98%
YTD
+25.68%
SMA 50 $183.88 · above
SMA 200 $164.10 · above
52W position 93%
BDX overview
Related filings and maps
Public disclosures
Congress activity in BDX
29 filers · 34 buys · 36 sells (0 labeled S (partial)) · Apr 16, 2013 to May 21, 2026 · House 64 / Senate 6
All available history · Latest 5 of 70 lines · Read Oct 18, 2026, 9:14 AM UTC
Official filing ↗
Becton, Dickinson and Company Common Stock · Transaction Mar 17, 2026 · Filed Apr 3, 2026 · $15,001 to $50,000
Becton, Dickinson and Company Common Stock · Transaction Jun 24, 2025 · Filed Aug 13, 2025 · $1,001 to $15,000
Becton, Dickinson and Company Common Stock · Transaction May 15, 2025 · Filed Jun 9, 2025 · $1,001 to $15,000
Becton, Dickinson and Company Common Stock · Transaction May 13, 2025 · Filed Jun 17, 2025 · $1,001 to $15,000
Federal contracts
BDX contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BDX in this window.
Lobbying spend
BDX lobbying filings, year to date.
Registered lobbying filings matched to Becton Dickinson and Co.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BDX in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for BDX.